| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 115.509 | 203.156 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 115.509 | 215.822 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 105.979 | 177.016 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | 9.531 | 38.805 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | 8.574 | 35.177 |
| Employees | - | - | - | - | - | - | - | - | 8 | 12 |
Check the financial reports for the company - Primam Nova Medica 98 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 99.172 | 120.775 |
| Current Assets | - | - | - | - | - | - | - | - | 18.674 | 26.049 |
| Inventories | - | - | - | - | - | - | - | - | 14.185 | 7.705 |
| Receivables | - | - | - | - | - | - | - | - | 0 | 5.939 |
| Cash | - | - | - | - | - | - | - | - | 4.490 | 12.405 |
| Shareholders Funds | - | - | - | - | - | - | - | - | 8.614 | 43.743 |
| Social Capital | - | - | - | - | - | - | - | - | 40 | 40 |
| Debts | - | - | - | - | - | - | - | - | 109.232 | 103.081 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8710 - 8710" | |||||||||
| CAEN Financial Year |
8710
|
|||||||||
Comments - Primam Nova Medica 98 S.r.l.